Kazunori Honda

Nagoya, 4648681, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study.

Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study.

Journal: Japanese journal of clinical oncology

Published: February 05, 2026

Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.

Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.

Journal: Therapeutic advances in medical oncology

Published: January 13, 2026

Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study.

Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study.

Journal: Japanese journal of clinical oncology

Published: November 12, 2025

Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan.

Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan.

Journal: Cancers

Published: October 14, 2025

Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study.

Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study.

Journal: Therapeutic advances in gastroenterology

Published: August 25, 2025

Relationship between programmed cell death ligand 1 expression and the number of biopsy specimens in advanced gastric cancer.

Relationship between programmed cell death ligand 1 expression and the number of biopsy specimens in advanced gastric cancer.

Journal: Journal of cancer research and clinical oncology

Published: June 06, 2025

Impact of nivolumab monotherapy infusion time-of-day on short- and long-term outcomes in patients with metastatic gastric cancer.

Impact of nivolumab monotherapy infusion time-of-day on short- and long-term outcomes in patients with metastatic gastric cancer.

Journal: Therapeutic advances in medical oncology

Published: January 25, 2025

Midline catheter use for cancer patients receiving 5-FU chemotherapy: prospective study of safety and outcomes.

Midline catheter use for cancer patients receiving 5-FU chemotherapy: prospective study of safety and outcomes.

Journal: The oncologist

Published: December 23, 2024

Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications.

Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 29, 2024

Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.

Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.

Journal: International journal of clinical oncology

Published: October 21, 2024

Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study.

Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study.

Journal: The oncologist

Published: August 30, 2024

Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer.

Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer.

Journal: International journal of clinical oncology

Published: August 16, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026